Jane Street Group, LLC Atossa Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $616 Billion
  • Q3 2025

A detailed history of Jane Street Group, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 162,428 shares of ATOS stock, worth $131,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
162,428
Previous 458,729 64.59%
Holding current value
$131,566
Previous $380,000 63.42%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$0.74 - $0.97 $219,262 - $287,411
-296,301 Reduced 64.59%
162,428 $139,000
Q2 2025

Aug 14, 2025
BUY
$0.59 - $1.03 $270,650 - $472,490
458,729 New
458,729 $380,000
Q4 2024

Feb 14, 2025
SELL
$0.94 - $1.62 $9,617 - $16,574
-10,231 Reduced 7.47%
126,704 $119,000
Q3 2024

Nov 14, 2024
SELL
$1.09 - $1.52 $134,229 - $187,181
-123,146 Reduced 47.35%
136,935 $208,000
Q2 2024

Aug 14, 2024
BUY
$1.03 - $2.1 $227,658 - $464,158
221,028 Added 565.97%
260,081 $309,000
Q1 2024

May 15, 2024
BUY
$0.8 - $1.89 $31,242 - $73,810
39,053 New
39,053 $70,000
Q3 2023

Nov 14, 2023
SELL
$0.74 - $1.35 $45,561 - $83,118
-61,569 Reduced 78.06%
17,302 $12,000
Q2 2023

Aug 14, 2023
BUY
$0.6 - $1.28 $33,786 - $72,076
56,310 Added 249.59%
78,871 $99,000
Q1 2023

May 15, 2023
SELL
$0.59 - $0.91 $12,572 - $19,392
-21,310 Reduced 48.57%
22,561 $16,000
Q4 2022

Feb 14, 2023
BUY
$0.5 - $1.01 $16,385 - $33,098
32,771 Added 295.23%
43,871 $23,000
Q3 2022

Nov 14, 2022
SELL
$0.82 - $1.14 $55,913 - $77,733
-68,187 Reduced 86.0%
11,100 $9,000
Q2 2022

Aug 16, 2022
SELL
$0.85 - $1.28 $33,295 - $50,138
-39,171 Reduced 33.07%
79,287 $86,000
Q1 2022

May 17, 2022
SELL
$1.11 - $1.74 $22,796 - $35,734
-20,537 Reduced 14.78%
118,458 $148,000
Q4 2021

Feb 15, 2022
SELL
$1.6 - $3.27 $129,193 - $264,039
-80,746 Reduced 36.75%
138,995 $222,000
Q3 2021

Nov 16, 2021
SELL
$2.89 - $6.4 $3.19 Million - $7.07 Million
-1,103,908 Reduced 83.4%
219,741 $716,000
Q2 2021

Aug 16, 2021
BUY
$1.52 - $8.62 $1.87 Million - $10.6 Million
1,228,839 Added 1296.11%
1,323,649 $8.37 Million
Q1 2021

May 18, 2021
BUY
$0.92 - $4.33 $87,225 - $410,527
94,810 New
94,810 $200,000
Q1 2019

May 16, 2019
SELL
$1.11 - $7.07 $24,796 - $157,936
-22,339 Closed
0 $0
Q4 2018

Feb 15, 2019
SELL
$0.92 - $1.67 $1,152 - $2,092
-1,253 Reduced 5.31%
22,339 $23,000
Q3 2018

Nov 14, 2018
BUY
$1.47 - $2.78 $34,680 - $65,585
23,592 New
23,592 $41,000

Others Institutions Holding ATOS

# of Institutions
75
Shares Held
26.8M
Call Options Held
79.5K
Put Options Held
98.8K
View Full List

About ATOSSA THERAPEUTICS, INC.

ATOS Quotes by TradingView
  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $103M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email